Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated High-Dose tDCS for Depression

NCT: NCT07226011 · RECRUITING

NCT IDNCT07226011
StatusRECRUITING
Start Date2025-12-15
Completion2026-08-01

Brief Summary

In this study, investigators are testing whether a higher dose of a non-invasive brain stimulation technique, called transcranial direct current stimulation (tDCS), can be safely used in people with depression. Participants will come to the Brain Stimulation Lab and receive mild electrical stimulation through electrodes placed on their scalp. The study begins with a safety run-in, where the first few participants will receive stimulation at gradually increasing levels (2, 4, and 6 milliamps) while being closely monitored. If no serious side effects are found, later participants will receive repeated 6 milliamp sessions for 5 days total. Investigators will check skin comfort, mood, and overall tolerability after each session.

Frequently Asked Questions

What is Accelerated High-Dose tDCS for Depression?

Accelerated High-Dose tDCS for Depression is a clinical trial registered under NCT07226011. Current status: RECRUITING.

What is the status of NCT07226011?

The current status of NCT07226011 (Accelerated High-Dose tDCS for Depression) is: RECRUITING.

When did Accelerated High-Dose tDCS for Depression start?

Accelerated High-Dose tDCS for Depression started on 2025-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.